微谱生物科技-值得信赖的生物药质量与安全研究伙伴

COMPANY PROFILE

WEIPU Biotechnology Co., Ltd.

WEIPU Biotechnology Co., Ltd., a wholly-owned subsidiary of WEIPU Group, was honored with the title of "Jiangsu Provincial Private Science and Technology Enterprise" in 2022. Rooted in the entire biopharmaceutical industry value chain, the company has established a mature biopharmaceutical R&D service platform through its innovative proprietary intellectual property system. Dedicated to providing global biopharmaceutical enterprises with integrated solutions including compliance, professional, and one-stop quality and safety research, regulatory validation consulting, and pharmaceutical packaging materials.

Currently, WEIPU Biotechnology operates a 8,000㎡ biosafety laboratory and holds ISO9001, CMA, and CNAS certifications. Combined with its 40,000㎡ biopharmaceutical laboratory platform, it offers comprehensive solutions for cell and gene therapies, antibody proteins, and other biotech products, meeting the regulatory requirements for drug registration in China, the United States, and Europe. Leveraging extensive project experience, a mature R&D system, rapid method development, and efficient testing cycles, the company has accelerated the development and market launch of nearly 500 products.

Explore more

The biosafety laboratory spans nearly

8000 m²
The biomedical laboratory
covers approximately

40000 m²
We have accelerated the development
and market launch of nearly

500 products
supported by precision instruments
from renowned brands

400